{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:16:55Z","timestamp":1775546215009,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"DOI":"10.1007\/s12223-026-01472-8","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:29:04Z","timestamp":1775543344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Colistin resistance and biofilm formation in carbapenem-resistant Acinetobacter baumannii isolates"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1286-7157","authenticated-orcid":false,"given":"Mehmet Akif","family":"Gun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kubra","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majda","family":"Licina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemilenur","family":"Atas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Yilmaz","family":"Coban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"1472_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/2049-632X.12125","volume":"71","author":"LC Antunes","year":"2014","unstructured":"Antunes LC, Visca P, Towner KJ (2014) Acinetobacter baumannii: evolution of a global pathogen. Pathogens and Disease 71:292\u2013301. https:\/\/doi.org\/10.1111\/2049-632X.12125","journal-title":"Pathogens and Disease"},{"key":"1472_CR2","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1017\/S095026881200194X","volume":"141","author":"H Aydemir","year":"2013","unstructured":"Aydemir H, Akduman D, Piskin N, Comert F, Horuz E, Terzi A et al (2013) Colistin vs the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. Epidemiol Infect 141:1214\u20131222. https:\/\/doi.org\/10.1017\/S095026881200194X","journal-title":"Epidemiol Infect"},{"key":"1472_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.apjtb.2016.04.006","volume":"6","author":"E Babapour","year":"2016","unstructured":"Babapour E, Haddadi A, Mirnejad R, Angaji SA, Amirmozafari N (2016) Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance. Asian Pacific Journal of Tropical Biomedicine 6:528\u2013533. https:\/\/doi.org\/10.1016\/j.apjtb.2016.04.006","journal-title":"Asian Pacific Journal of Tropical Biomedicine"},{"key":"1472_CR4","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/jac\/dks084","volume":"67","author":"Y Cai","year":"2012","unstructured":"Cai Y, Chai D, Wang R, Liang B, Bai N (2012) Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms, and antimicrobial strategies. J Antimicrob Chemother 67:1607\u20131615. https:\/\/doi.org\/10.1093\/jac\/dks084","journal-title":"J Antimicrob Chemother"},{"key":"1472_CR5","unstructured":"Centers for Disease Control and Prevention (2019) Antibiotic resistance threats in the United States, 2019. https:\/\/www.cdc.gov\/antimicrobial-resistance\/media\/pdfs\/2019-ar-threats-report-508.pdf. Accessed 18 Feb 2026"},{"key":"1472_CR6","unstructured":"CLSI (2020) Performance standards for antimicrobial susceptibility testing. CLSI supplement M100, 30th edn. Clinical and Laboratory Standards Institute, Wayne, PA"},{"key":"1472_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/AAC.01388-10","volume":"55","author":"S Coyne","year":"2011","unstructured":"Coyne S, Courvalin P, P\u00e9richon B (2011) Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 55:947\u2013953. https:\/\/doi.org\/10.1128\/AAC.01388-10","journal-title":"Antimicrob Agents Chemother"},{"key":"1472_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrd1008","volume":"2","author":"D Davies","year":"2003","unstructured":"Davies D (2003) Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2:114\u2013122. https:\/\/doi.org\/10.1038\/nrd1008","journal-title":"Nat Rev Drug Discov"},{"key":"1472_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/cid\/ciy988","volume":"69","author":"Y Dickstein","year":"2019","unstructured":"Dickstein Y, Lellouche J, Ben Dalak Amar M, Schwartz D, Nutman A, Daitch V et al (2019) Treatment outcomes of colistin- and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial. Clin Infect Dis 69:769\u2013776. https:\/\/doi.org\/10.1093\/cid\/ciy988","journal-title":"Clin Infect Dis"},{"key":"1472_CR10","unstructured":"ECDC (2017) Annual epidemiological report for 2017 \u2013 Acinetobacter infections. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER_for_2017-HAI.pdf. Accessed 18 Feb 2026"},{"key":"1472_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jhin.2011.08.013","volume":"80","author":"P Espinal","year":"2012","unstructured":"Espinal P, Mart\u00ed S, Vila J (2012) Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect 80:56\u201360. https:\/\/doi.org\/10.1016\/j.jhin.2011.08.013","journal-title":"J Hosp Infect"},{"key":"1472_CR12","unstructured":"EUCAST (2025) Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0. https:\/\/www.eucast.org. Accessed 18 Feb 2026"},{"key":"1472_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jgar.2021.08.004","volume":"27","author":"EC Eze","year":"2021","unstructured":"Eze EC, El Zowalaty ME, Pillay M (2021) Antibiotic resistance and biofilm formation of Acinetobacter baumannii isolated from high-risk effluent water in tertiary hospitals in South Africa. J Glob Antimicrob Resist 27:82\u201390. https:\/\/doi.org\/10.1016\/j.jgar.2021.08.004","journal-title":"J Glob Antimicrob Resist"},{"key":"1472_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02192","volume":"5","author":"G Gebreyohannes","year":"2019","unstructured":"Gebreyohannes G, Nyerere A, Bii C, Sbhatu DB (2019) Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon 5:e02192. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02192","journal-title":"Heliyon"},{"key":"1472_CR15","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/j.1462-5822.2009.01323.x","volume":"11","author":"L Hall-Stoodley","year":"2009","unstructured":"Hall-Stoodley L, Stoodley P (2009) Evolving concepts in biofilm infections. Cell Microbiol 11:1034\u20131043. https:\/\/doi.org\/10.1111\/j.1462-5822.2009.01323.x","journal-title":"Cell Microbiol"},{"key":"1472_CR16","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000306","volume":"5","author":"M Hamidian","year":"2019","unstructured":"Hamidian M, Nigro SJ (2019) Emergence, molecular mechanisms, and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom 5:e000306. https:\/\/doi.org\/10.1099\/mgen.0.000306","journal-title":"Microb Genom"},{"key":"1472_CR17","doi-asserted-by":"publisher","unstructured":"H\u00f8iby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen P\u00d8 et al (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3:55\u201365. https:\/\/doi.org\/10.4248\/IJOS11026","DOI":"10.4248\/IJOS11026"},{"key":"1472_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01110-18","volume":"63","author":"B Isler","year":"2018","unstructured":"Isler B, Doi Y, Bonomo RA, Paterson DL (2018) New treatment options against carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother 63:e01110-18. https:\/\/doi.org\/10.1128\/AAC.01110-18","journal-title":"Antimicrob Agents Chemother"},{"key":"1472_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.yrtph.2009.01.004","volume":"53","author":"SH Jeong","year":"2009","unstructured":"Jeong SH, Song YK, Cho JH (2009) Risk assessment of ciprofloxacin, flavomycin, olaquindox, and colistin sulfate based on microbiological impact on human gut biota. Regul Toxicol Pharmacol 53:209\u2013216. https:\/\/doi.org\/10.1016\/j.yrtph.2009.01.004","journal-title":"Regul Toxicol Pharmacol"},{"key":"1472_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14060266","volume":"14","author":"W Katip","year":"2022","unstructured":"Katip W, Oberdorfer P, Kasatpibal N (2022) Effectiveness and nephrotoxicity of loading dose colistin\u2013meropenem versus loading dose colistin\u2013imipenem in the treatment of carbapenem-resistant Acinetobacter baumannii infection. Pharmaceutics 14:1266. https:\/\/doi.org\/10.3390\/pharmaceutics14060266","journal-title":"Pharmaceutics"},{"key":"1472_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jiph.2024a.03.010","volume":"17","author":"W Katip","year":"2024","unstructured":"Katip W, Rayanakorn A, Oberdorfer P, Taruangsri P, Nampuan T, Okonogi S (2024a) Comparative effectiveness and mortality of colistin monotherapy versus colistin\u2013fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae infections: a propensity score analysis. J Infect Public Health 17:727\u2013734. https:\/\/doi.org\/10.1016\/j.jiph.2024a.03.010","journal-title":"J Infect Public Health"},{"key":"1472_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13030287","volume":"13","author":"W Katip","year":"2024","unstructured":"Katip W, Rayanakorn A, Sornsuvit C, Wientong P, Oberdorfer P, Taruangsri P, Nampuan T (2024b) High-loading-dose colistin with nebulized administration for carbapenem-resistant Acinetobacter baumannii pneumonia in critically ill patients: a retrospective cohort study. Antibiotics 13:287. https:\/\/doi.org\/10.3390\/antibiotics13030287","journal-title":"Antibiotics"},{"key":"1472_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/mdr.2014.0236","volume":"21","author":"HA Kim","year":"2015","unstructured":"Kim HA, Ryu SY, Seo I, Suh SI, Suh MH, Baek WK (2015) Biofilm formation and colistin susceptibility of Acinetobacter baumannii isolated from Korean nosocomial samples. Microb Drug Resist 21:452\u2013457. https:\/\/doi.org\/10.1089\/mdr.2014.0236","journal-title":"Microb Drug Resist"},{"key":"1472_CR24","doi-asserted-by":"publisher","unstructured":"Li Z, Ding Z, Liu Y, Jin X, Xie J, Li T et al (2021) Phenotypic and genotypic characteristics of biofilm formation in clinical isolates of Acinetobacter baumannii. Infect Drug Resist 14:2613\u20132624. https:\/\/doi.org\/10.2147\/IDR.S310081","DOI":"10.2147\/IDR.S310081"},{"key":"1472_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"YY Liu","year":"2016","unstructured":"Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J et al (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161\u2013168. https:\/\/doi.org\/10.1016\/S1473-3099(15)00424-7","journal-title":"Lancet Infect Dis"},{"key":"1472_CR26","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1128\/JB.01416-07","volume":"190","author":"TW Loehfelm","year":"2008","unstructured":"Loehfelm TW, Luke NR, Campagnari AA (2008) Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J Bacteriol 190:1036\u20131044. https:\/\/doi.org\/10.1128\/JB.01416-07","journal-title":"J Bacteriol"},{"key":"1472_CR27","first-page":"119","volume":"37","author":"F Longo","year":"2014","unstructured":"Longo F, Vuotto C, Donelli G (2014) Biofilm formation in Acinetobacter baumannii. New Microbiol 37:119\u2013127","journal-title":"New Microbiol"},{"key":"1472_CR28","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/529198","volume":"46","author":"LL Maragakis","year":"2008","unstructured":"Maragakis LL, Perl TM (2008) Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46:1254\u20131263. https:\/\/doi.org\/10.1086\/529198","journal-title":"Clin Infect Dis"},{"key":"1472_CR29","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1128\/AAC.00834-10","volume":"54","author":"JH Moffatt","year":"2010","unstructured":"Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T et al (2010) Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 54:4971\u20134977. https:\/\/doi.org\/10.1128\/AAC.00834-10","journal-title":"Antimicrob Agents Chemother"},{"key":"1472_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev.micro.54.1.49","volume":"54","author":"G O\u2019Toole","year":"2000","unstructured":"O\u2019Toole G, Kaplan HB, Kolter R (2000) Biofilm formation as microbial development. Annu Rev Microbiol 54:49\u201379. https:\/\/doi.org\/10.1146\/annurev.micro.54.1.49","journal-title":"Annu Rev Microbiol"},{"key":"1472_CR31","first-page":"86","volume":"66","author":"ME Olson","year":"2002","unstructured":"Olson ME, Ceri H, Morck DW, Buret AG, Read RR (2002) Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 66:86\u201392","journal-title":"Can J Vet Res"},{"key":"1472_CR32","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1128\/AAC.01464-06","volume":"51","author":"F Perez","year":"2007","unstructured":"Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA (2007) The global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51:3471\u20133484. https:\/\/doi.org\/10.1128\/AAC.01464-06","journal-title":"Antimicrob Agents Chemother"},{"key":"1472_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.00064-16","volume":"30","author":"L Poirel","year":"2017","unstructured":"Poirel L, Jayol A, Nordmann P (2017) Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 30:557\u2013596. https:\/\/doi.org\/10.1128\/CMR.00064-16","journal-title":"Clin Microbiol Rev"},{"key":"1472_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103887","volume":"139","author":"A Pormohammad","year":"2020","unstructured":"Pormohammad A, Mehdinejadiani K, Gholizadeh P, Nasiri MJ, Mohtavinejad N, Dadashi M et al (2020) Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis. Microb Pathog 139:103887. https:\/\/doi.org\/10.1016\/j.micpath.2019.103887","journal-title":"Microb Pathog"},{"key":"1472_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00483","volume":"7","author":"L Qi","year":"2016","unstructured":"Qi L, Li H, Zhang C, Liang B, Li J, Wang L et al (2016) Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Front Microbiol 7:483. https:\/\/doi.org\/10.3389\/fmicb.2016.00483","journal-title":"Front Microbiol"},{"key":"1472_CR36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4155\/fmc.15.7","volume":"7","author":"N Rabin","year":"2015","unstructured":"Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO (2015) Agents that inhibit bacterial biofilm formation. Future Med Chem 7:647\u2013671. https:\/\/doi.org\/10.4155\/fmc.15.7","journal-title":"Future Med Chem"},{"key":"1472_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.793615","volume":"9","author":"S Roy","year":"2022","unstructured":"Roy S, Chowdhury G, Mukhopadhyay AK, Dutta S, Basu S (2022) Convergence of biofilm formation and antibiotic resistance in Acinetobacter baumannii infection. Frontiers in Medicine 9:793615. https:\/\/doi.org\/10.3389\/fmed.2022.793615","journal-title":"Frontiers in Medicine"},{"key":"1472_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.676458","volume":"12","author":"R Srinivasan","year":"2021","unstructured":"Srinivasan R, Santhakumari S, Poonguzhali P, Geetha M, Dyavaiah M, Xiangmin L (2021) Bacterial biofilm inhibition: a focused review on recent therapeutic strategies for combating the biofilm mediated infections. Front Microbiol 12:676458. https:\/\/doi.org\/10.3389\/fmicb.2021.676458","journal-title":"Front Microbiol"},{"key":"1472_CR39","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"S Stepanovi\u0107","year":"2007","unstructured":"Stepanovi\u0107 S, Vukovi\u0107 D, Hola V, Di Bonaventura G, Djuki\u0107 S, Cirkovi\u0107 I, Ruzicka F (2007) Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115:891\u2013899. https:\/\/doi.org\/10.1111\/j.1600-0463.2007.apm_630.x","journal-title":"APMIS"},{"key":"1472_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.679241","volume":"12","author":"X Sun","year":"2021","unstructured":"Sun X, Ni Z, Tang J, Ding Y, Wang X, Li F (2021) The abaI\/abaR quorum sensing system effects on pathogenicity in Acinetobacter baumannii. Front Microbiol 12:679241. https:\/\/doi.org\/10.3389\/fmicb.2021.679241","journal-title":"Front Microbiol"},{"key":"1472_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104997","volume":"157","author":"Y Usmani","year":"2021","unstructured":"Usmani Y, Ahmed A, Faizi S, Versiani MA, Shamshad S, Khan S et al (2021) Antimicrobial and biofilm inhibiting potential of an amide derivative [N-(2\u2019, 4\u2019-dinitrophenyl)-3\u03b2-hydroxyurs-12-en-28-carbonamide] of ursolic acid by modulating membrane potential and quorum sensing against colistin resistant Acinetobacter baumannii. Microb Pathog 157:104997. https:\/\/doi.org\/10.1016\/j.micpath.2021.104997","journal-title":"Microb Pathog"},{"key":"1472_CR42","unstructured":"World Health Organization (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. https:\/\/www.who.int\/publications\/i\/item\/WHO-EMP-IAU-2017.12.\u00a0Accessed 18 Feb 2026"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01472-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-026-01472-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01472-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:29:10Z","timestamp":1775543350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-026-01472-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":42,"alternative-id":["1472"],"URL":"https:\/\/doi.org\/10.1007\/s12223-026-01472-8","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Akdeniz University Ethics Committee for Medical Scientific Research (Decision No: TBAEK-221, 28 March 2024). Informed consent was waived as no patient-identifiable data were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}